Trends of antimicrobial resistance in Escherichia coli isolates from urine cultures of women in Jordan: A 10-year retrospective study
Keywords:Antimicrobial resistance, E.coli resistance, urinary tract infection, women, Jordan
Background: Urinary tract infection (UTI) is a common medical condition among women. E.coli is the most common causative organism. Appropriate understanding of the development of antimicrobial resistance over the past helps to establish efficient treatment strategies in the future. The study aims to discover antimicrobial resistance trends exhibited by E.coli strains isolated from women urine cultures over the past 10 years.
Methods: A total of 1874 affected urine samples over the years 2009 to 2018 were collectively reviewed and classified according to the response they showed to 24 different antimicrobial disks in the laboratory. Relations between time and resistance evolutionary profiles were calculated.
Results: Gentamicin (p value =0.039), Augmentin (p value =0.017), Cefoxitin (p value =0.001), Cefixime (p value =0.026) fulfilled satisfactory figures in terms of average resistance, regression of resistance, speed of resistance evolution, steadiness of performance, side effects, spectrum range and cost with high significance.
Conclusion: Drugs that showed satisfactory figures are recommended for future treatment protocols in Jordan.
Aslam B, Wang W, Arshad MI, Khurshid M, Muzammil S, Rasool MH, et al. Antibiotic resistance: a rundown of a global crisis. Infection and drug resistance. 2018;11:1645.
Cag Y, Caskurlu H, Fan Y, Cao B, Vahaboglu H. Resistance mechanisms. Annals of translational medicine. 2016;4.
Li B, Webster TJ. Bacteria antibiotic resistance: New challenges and opportunities for implantâ€associated orthopedic infections. Journal of Orthopaedic ResearchÂ®. 2018;36:22-32.
Allcock S, Young E, Holmes M, Gurdasani D, Dougan G, Sandhu M, et al. Antimicrobial resistance in human populations: challenges and opportunities. Global health, epidemiology and genomics. 2017;2.
Soto SM. Role of efflux pumps in the antibiotic resistance of bacteria embedded in a biofilm. Virulence. 2013;4:223-9.
Lee C-R, Cho IH, Jeong BC, Lee SH. Strategies to minimize antibiotic resistance. International journal of environmental research and public health. 2013;10:4274-305.
Schmiemann G, Kniehl E, Gebhardt K, Matejczyk MM, Hummers-Pradier E. The diagnosis of urinary tract infection: a systematic review. Deutsches Ã„rzteblatt International. 2010;107:361.
PIÄ„TEK BMZ. Urinary tract infections of Escherichia coli strains of chaperone-usher system. Polish journal of microbiology. 2011;60:279-85.
Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nature reviews microbiology. 2015;13:269.
Simmering JE, Tang F, Cavanaugh JE, Polgreen LA, Polgreen PM. The increase in hospitalizations for urinary tract infections and the associated costs in the United States, 1998â€“2011. Open forum infectious diseases: Oxford University Press; 2017.
Al-Badr A, Al-Shaikh G. Recurrent urinary tract infections management in women: a review. Sultan Qaboos University Medical Journal. 2013;13:359.
Jordan University Hospital Pharmacy Reports of Imported Drugs Quantities. Amman,Jordan: Jordan University Hospital; 2009-2018.
Brusch JL, Bavaro M, Cunha B, Tessier J. Urinary Tract Infection (UTI) and Cystitis (Bladder Infection) in Females Treatment & Management. Medscape Reference; 2019.
M100, Performance Standards for Antimicrobial Susceptibility Testing. West Vally Road, Suite 2500 Wayne, New Jersey, USA: Clinical and Laboratory Standards Institute; 2017.
Antimicrobial Stewardship Strategy:Formulary restriction. Toronto, ON: Queenâ€™s Printer for Ontario: Ontario Agency for Health Protection and Promotion (Public Health Ontario); 2016.
Antimicrobial Stewardship Program strategy criteria reference guide. Toronto, ON: Queenâ€™s Printer for Ontario: Ontario Agency for Health Protection and Promotion (Public Health Ontario); 2015.
Belyayeva M, Jeong JM. Acute Pyelonephritis. StatPearls [Internet]: StatPearls Publishing; 2019.
Minardi D, dâ€™Anzeo G, Cantoro D, Conti A, Muzzonigro G. Urinary tract infections in women: etiology and treatment options. International journal of general medicine. 2011;4:333.https://doi.org/10.2147/ijgm.s11767.
Ahmed A-fA-m, Solyman AA-k, Kamal SM. Potential host-related risk factors for recurrent urinary tract infection in Saudi women of childbearing age. International urogynecology journal. 2016;27:1245-53.
Mittal S, Kumar A, Govil N. Urinary Tract Infection: General Considerations. 2015.
Bajaj P, Singh NS, Virdi JS. Escherichia coli Î²-lactamases: what really matters. Frontiers in microbiology. 2016;7:417.
Fasugba O, Gardner A, Mitchell BG, Mnatzaganian G. Ciprofloxacin resistance in community-and hospital-acquired Escherichia coli urinary tract infections: a systematic review and meta-analysis of observational studies. BMC infectious diseases. 2015;15:545.
National Action Plan to Combat Antimicrobial Resistance. Hashimate Kingdom of Jordan: Ministry of Health; 2018.
Antimicrobial Resistance : National action plans. World Health Organization; 2016.
Joint Commission International Accreditation Standards for Hospitals. 5th ed. Oakbrook Terrace, Illinois 60181 US: Joint Commission International; 2014.
Jordan National Drug Formulary (JNDF). 2nd ed. Jordan: Ministry of Health; 2011.
Cho S-Y, Choi S-M, Park SH, Lee D-G, Choi J-H, Yoo J-H. Amikacin therapy for urinary tract infections caused by extended-spectrum Î²-lactamase-producing Escherichia coli. The Korean journal of internal medicine. 2016;31:156.
Hasvold J, Bradford L, Nelson C, Harrison C, Attar M, Stillwell T. Gentamicin resistance among Escherichia coli strains isolated in neonatal sepsis. Journal of neonatal-perinatal medicine. 2013;6:173-7.
Gregson DB, Matlow AG, Simor AE, Tuffnell PG, Low DE, Feld R, et al. Cotrimoxazole-resistant Escherichia coli bacteremia in neutropenic patients at a regional oncology hospital. Canadian Journal of Infectious Diseases and Medical Microbiology. 1992;3:14-8.
Leigh A. Augmentin (Amoxycillin and Clavulanic Acid) in the Treatment of Urinary Tract Infections. Scottish medical journal. 1982;27:S28-S34.
Zhang H, Kong H, Yu Y, Wu A, Duan Q, Jiang X, et al. Carbapenem susceptibilities of Gram-negative pathogens in intra-abdominal and urinary tract infections: updated report of SMART 2015 in China. BMC infectious diseases. 2018;18:493.
Niranjan V, Malini A. Antimicrobial resistance pattern in Escherichia coli causing urinary tract infection among inpatients. The Indian journal of medical research. 2014;139:945.
Chua KY, Stewardson AJ. Individual and community predictors of urinary ceftriaxone-resistant Escherichia coli isolates, Victoria, Australia. Antimicrobial Resistance & Infection Control. 2019;8:36.
Endimiani A, Perez F, Bonomo RA. Cefepime: a reappraisal in an era of increasing antimicrobial resistance. Expert review of anti-infective therapy. 2008;6:805-24.
Kapoor A, Raju S. Illustrated medical pharmacology: JP Medical Ltd; 2013.
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access and Benefits of Publishing Open Access).
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
Articles are published Under License of Creative Commons Attribution 3.0 License Â©
Copyright policies & self-archiving
|Author's Pre-print:||author can archive pre-print (ie pre-refereeing)|
|Author's Post-print:||author can archive post-print (ie final draft post-refereeing)|
|Publisher's Version/PDF:||author can archive publisher's version/PDF|